The manufacturing plant will make experimental biotech drugs for clinical trials, its first product being an antibody designed to stimulate the patient’s immune system to fight cancer. It is hoped the plant will make five or six drugs for clinical trials in the course of one year. There is also likley to be some capacity for use of the lab by pharmaceutical and biotech companies.
Speaking of the new Biotherapeutics Development Unit, Heike Lentfer, head of the manufacturing unit, stated: “It’s a real boost being able to make the products that our scientists need for life-saving research into cancer – it is more cost effective and efficient, allowing us to work in a more innovative way to find exciting new treatments to beat cancer.”
Until this point, Cancer Research UK has mainly outsourced the manufacturing of biotech products such as antibodies now used in cancer treatments.
Are you looking for work in clinical trials or oncology? Click here to search our current job vacancies now.